Our Specialists

Dr Kenneth Koo is a Senior Staff Specialist at the Department of Gastroenterology and Liver at Liverpool Hospital and a Conjoint Senior Lecturer at the University of New South Wales. Dr Koo graduated from the University of Melbourne and completed post-graduate advanced training in Gastroenterology at Liverpool, Bankstown and Canberra Hospitals. Dr Koo was awarded the Fellowship of the Royal Australasian College of Physicians (FRACP) in 2005, and a PhD in the field of clinical epidemiology in bowel cancer in 2012 from the University of New South Wales.

Dr Koo's clinical interest include screening for and surveillance of bowel cancer and polyps, the diagnosis and management of inflammatory and functional bowel diseases, chronic liver disease and small bowel disease. Dr Koo is accredited for gastroscopy, colonoscopy and capsule endoscopy by the Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy.

His clinical research interests include screening for bowel cancer and quality assurance in endoscopy and their outcomes. He is the clinical lead for the Direct Access Colonoscopy service which facilitates rapid, efficient and safe colonoscopy access for patients with positive faecal occult blood test. He supervises Advance and Basic Physician trainees and students in the Independent Learning Project and is actively involved in teaching junior medical officers and medical students.

MBBS
University of Melbourne 1995

FRACP
Fellowship of the Royal Australian College of Physicians 2005

Ph.D. in Medicine Dissertation
Colorectal Cancer in Sydney South West Area Health Service, University of New South Wales 2012

Conjoint Committee Certified in
Gastroscopy, colonoscopy and capsule endoscopy

Staff Specialist, Gastroenterologist and Hepatologist (2007 – present)
Liverpool Hospital

Conjoint Senior Lecturer (2002 – present)
University of New South Wales

1. MA Guliyara, G Ermerak, JH Koo et al. Frailty predicts mortality in patients with upper gastrointestinal bleed: A prospective cohort study. J Gastroenterol Hepatol; 2023; 38:8: 1292-98.
2. N Rattan, L Willmann, JH Koo et al. To scope or not-the challenges of managing patients with positive fecal occult blood test after recent colonoscopy. World Journal of Gastrointestinal Oncology 2022; 14:9:1798
3. MA Guliyara, JH Koo. Jejunal Metastasis from Hepatocellular Carcinoma. ACG Case Reports Journal 2022; 9:8, e00843
4. Wu Y, Wen A, JH Koo et al. Management decisions in Crohn’s Disease are changed by knowledge of proactive and reactive testing of antitumor necrosis factor drug levels. Crohn’s and Colitis 360; 2021: 3.
5. Mohsen W, Williams AJ, JH Koo et al. Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy? World J Gastroenterol 2021; 27: 1090
6. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Koo JH, Leong RW, Ching J, Yeoh KG, Wu DC, Murdani A, Cai Q, Chiu HM, Chong VH, Rerknimitr R, Goh KL, Hilmi I, Byeon JS, Niaz SK, Siddique A, Wu KC, Matsuda T, Makharia G, Sollano J, Lee SK, Sung JJ; Asia Pacific Working Group in Colorectal Cancer. Gastrointest Endosc. 2012 Jul;76(1):126-35. doi: 10.1016/j.gie.2012.03.168. PMID: 22726471